Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein deglycase DJ-1, encoded by the PARK7 gene, is a ubiquitous and multifunctional protein essential for cellular protection against oxidative stress and mitochondrial dysfunction (UniProt P59998). It functions primarily as a redox-sensitive chaperone and an enzyme that repairs glycated proteins, thereby preventing the accumulation of advanced glycation end-products (PubMed: 28106294). In the context of neurodegeneration, particularly Parkinson's disease, loss-of-function mutations in DJ-1 lead to early-onset pathology, making the restoration of its activity a primary therapeutic goal (PubMed: 12446770). Current research focuses on the DJ-1 pathway via gene overexpression using viral vectors to increase protein levels in the substantia nigra, aiming to provide neuroprotection and reduce alpha-synuclein toxicity (PubMed: 31430310). While promising for neurodegenerative disorders, the therapeutic application must be balanced against DJ-1's role as an oncogene, where its overexpression is associated with increased cell proliferation and resistance to apoptosis in various cancers (PubMed: 19249685). Consequently, therapeutic strategies must carefully titrate DJ-1 levels to achieve neuroprotection without inducing malignant transformation. Small molecule stabilizers and inducers are also being explored to enhance the endogenous activity of the DJ-1 pathway.
Gene overexpression to increase protein levels and enhance antioxidant/chaperone activity; stabilization of the DJ-1 homodimer to maintain functional integrity.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein deglycase DJ-1 (DJ-1) (DJ-1).